Feng Tian

1.1k total citations
41 papers, 828 citations indexed

About

Feng Tian is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Feng Tian has authored 41 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Oncology and 10 papers in Immunology. Recurrent topics in Feng Tian's work include Cancer Immunotherapy and Biomarkers (6 papers), Immune Response and Inflammation (5 papers) and Analytical Methods in Pharmaceuticals (4 papers). Feng Tian is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Immune Response and Inflammation (5 papers) and Analytical Methods in Pharmaceuticals (4 papers). Feng Tian collaborates with scholars based in China, United States and Germany. Feng Tian's co-authors include Tao Jiang, Xiaolong Yan, Yunfeng Ni, Yunjie Wang, Jinbo Zhao, Jian Wang, Xiaofei Li, Jiakuan Chen, Deguang Mu and Yunsheng Hu and has published in prestigious journals such as PLoS ONE, Analytical Chemistry and Clinical Cancer Research.

In The Last Decade

Feng Tian

41 papers receiving 815 citations

Peers

Countries citing papers authored by Feng Tian

Since Specialization

Citations

This map shows the geographic impact of Feng Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Tian more than expected).

Fields of papers citing papers by Feng Tian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Tian. The network helps show where Feng Tian may publish in the future.

Co-authorship network of co-authors of Feng Tian

This figure shows the co-authorship network connecting the top 25 collaborators of Feng Tian. A scholar is included among the top collaborators of Feng Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng Tian. Feng Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CRABP2 (Cellular Retinoic Acid Binding Protein 2D): A novel biomarker for the diagnosis and prognosis involved in immune infiltration of lung adenocarcinoma 2025 ·Journal of Cancer ·(unknown), Feng Tian, Dengke Zhang, (unknown), Yonghui Wang	1
2	Plexin D1 mediates disturbed flow-induced M1 macrophage polarization in atherosclerosis 2023 ·Heliyon ·Suhui Zhang, Yingqian Zhang, (unknown), (unknown), (unknown), Wei Wang, (unknown), Feng Tian, Hui Hui, Jie Tian, Yundai Chen	5
3	Regulation of CD18 stability by SIGIRR ‐modulated ubiquitination: new insights into the relationship between innate immune response and acute lung injury 2022 ·FEBS Journal ·Feng Tian, Jie Lei, Yunfeng Ni, Daixing Zhong, (unknown), Jun Ma, Hai‐Qiang Wang, (unknown), Yumei Wu, Tao Jiang	3
4	Inactivation of TMEM106A promotes lipopolysaccharide-induced inflammation via the MAPK and NF-κB signaling pathways in macrophages 2020 ·Clinical & Experimental Immunology ·Xuan Zhang, Feng Tian, Xin Zhou, Peter M. Sullivan, (unknown), Yue Lou, Jin Yu, Jie Feng, (unknown), Yingyu Chen	15
5	Simultaneous Determination of Rivaroxaban and TAK-438 in Rat Plasma by LC–MS/MS: Application to Pharmacokinetic Interaction Study 2019 ·Bioanalysis ·Libin Wang, (unknown), Xiaorui Zhang, Xiaohui Xu, (unknown), Xingchen Wang, Nan Zhou, Feng Tian	11
6	The pronounced high expression of discoidin domain receptor 2 in human interstitial lung diseases 2018 ·ERJ Open Research ·Huan Bian, Xiaowei Nie, Xin Bu, Feng Tian, Libo Yao, Jingyu Chen, Jin Su	10
7	Salidroside, a scavenger of ROS, enhances the radioprotective effect of Ex-RAD® via a p53-dependent apoptotic pathway 2017 ·Oncology Reports ·Feng Tian, Libin Wang, Nan Zhou, Chang Liu, (unknown), (unknown), (unknown), Shengyong Zhang, Hui Chen, Siwang Wang	17
8	High ABCG4 Expression Is Associated with Poor Prognosis in Non-Small-Cell Lung Cancer Patients Treated with Cisplatin-Based Chemotherapy 2015 ·PLoS ONE ·Guang Yang, Xuejiao Wang, Lijun Huang, Yongan Zhou, Feng Tian, Jinbo Zhao, Peng Chen, Boya Liu, (unknown), Xiaofei Li, Zhipei Zhang	17
9	Intrathymic Tfh/B Cells Interaction Leads to Ectopic GCs Formation and Anti-AChR Antibody Production: Central Role in Triggering MG Occurrence 2014 ·Molecular Neurobiology ·Xiaoyan Zhang, Shasha Liu, Ting Chang, Xu Jiang, Chunmei Zhang, Feng Tian, Yuanjie Sun, Chaojun Song, Wei Yi, Hong Lin, Zhuyi Li, Kun Yang	46
10	Thymic TFH cells involved in the pathogenesis of myasthenia gravis with thymoma 2014 ·Experimental Neurology ·Min Zhang, Yongan Zhou, Jun Guo, Hongzeng Li, Feng Tian, Li Gong, (unknown), Lan Miao, Zhuyi Li, Wei Zhang	23
11	AR3 messenger ribonucleic acid expression and its functional implication in human primary testicular failure 2013 ·Andrologia ·Feng Tian, Yan Wu, Jie Zhao, Wenhao Li	3
12	α-linolenic acid inhibits human renal cell carcinoma cell proliferation through PPAR-γ activation and COX-2 inhibition 2013 ·Oncology Letters ·Lijun Yang, Jianlin Yuan, Liwen Liu, Changhong Shi, Longxin Wang, Feng Tian, Fei Liu, He Wang, Chen Shao, Qiang Zhang, Zhi‐Nan Chen, Weijun Qin, Weihong Wen	39
13	Exosomes derived from Rab27a-overexpressing tumor cells elicit efficient induction of antitumor immunity 2013 ·Molecular Medicine Reports ·Wenhai Li, Deguang Mu, Feng Tian, Yunsheng Hu, (unknown), Yong Han, Jiakuan Chen, (unknown), Xiaofei Li	101
14	Protective Effect of Nicotine on Lipopolysaccharide-Induced Acute Lung Injury in Mice 2010 ·Respiration ·(unknown), Feng Tian, (unknown), (unknown), (unknown), Jian Wang, (unknown), (unknown), (unknown), Tao Jiang	27
15	Histone deacetylase inhibitor, butyrate, attenuates lipopolysaccharide-induced acute lung injury in mice 2010 ·Respiratory Research ·Yunfeng Ni, Jian Wang, Xiaolong Yan, Feng Tian, Jinbo Zhao, Yunjie Wang, Tao Jiang	109
16	Immunotherapy for Human Renal Cell Carcinoma by Adoptive Transfer of Autologous Transforming Growth Factor β–Insensitive CD8+ T Cells 2009 ·Clinical Cancer Research ·Longxin Wang, Weihong Wen, Jianlin Yuan, Brian T. Helfand, Li Yu, Changhong Shi, Feng Tian, (unknown), Fuli Wang, Lin Chen, Li‐Li Liang, Liqun Zhou, Chung Lee, Zhi‐Nan Chen, Yinglu Guo, He Wang, Qiang Zhang, Weijun Qin	35
17	Single immunoglobulin IL-1 receptor-related protein attenuates the lipopolysaccharide-induced inflammatory response in A549 cells 2009 ·Chemico-Biological Interactions ·Feng Tian, (unknown), Jinbo Zhao, Zhipei Zhang, Huizhong Zhang, Li Liu, (unknown), Yunjie Wang	16
18	Vaccination with transforming growth factor-beta insensitive dendritic cells suppresses pulmonary metastases of renal carcinoma in mice 2008 ·Cancer Letters ·Feng Tian, Longxin Wang, Weijun Qin, Fuli Wang, Bin Song, Yu Li, Weihong Wen, Zheng Zhang, (unknown), Qiang Zhang, Chung Lee, Weide Zhong, Yinglu Guo, He Wang	8
19	TGF-β insensitive dendritic cells: an efficient vaccine for murine prostate cancer 2007 ·Cancer Immunology Immunotherapy ·(unknown), (unknown), (unknown), Feng Tian, Bin Song, Qiang Zhang, Chung Lee, Weide Zhong, (unknown), He Wang	16
20	Meta-analysis of risk factors of esophageal cancer in China 2003 ·Di-Si Junyi Daxue xuebao ·Feng Tian	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact